Malignant peripheral nerve-sheath tumors in an adolescent patient with mosaic localized NF1: A case report

被引:3
|
作者
Hagizawa, Hiroki [1 ]
Nagata, Shigenori [2 ]
Wakamatsu, Toru [1 ]
Imura, Yoshinori [1 ]
Tanaka, Takaaki [1 ]
Outani, Hidetatsu [3 ]
Konishi, Eiichi [4 ]
Naka, Norifumi [1 ]
Tamiya, Hironari [1 ]
机构
[1] Osaka Int Canc Inst, Dept Orthoped Surg, Osaka 5418567, Japan
[2] Osaka Int Canc Inst, Dept Diagnost Pathol & Cytol, Osaka 5418567, Japan
[3] Osaka Univ Hosp, Dept Orthoped Surg, Suita, Osaka 5650871, Japan
[4] Kyoto Prefectural Univ Med, Dept Pathol, Kyoto 6028566, Japan
基金
日本学术振兴会;
关键词
neurofibromatosis type 1; mosaic localized; cafe-au-lait spot; malignant peripheral nerve-sheath tumor; adolescent; SEGMENTAL NEUROFIBROMATOSIS;
D O I
10.3892/mco.2019.1969
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant peripheral nerve-sheath tumors (MPNSTs) are rare malignancies that are often observed in patients with neurofibromatosis type 1 (NF1). However, the occurrence of MPNST associated with mosaic localized NF1 is extremely rare. Previous reports have revealed that MPNST was associated with mosaic localized NF1 in only three patients who were >40 years of age. The present report details a 16-year-old man who presented with pain and a 3 cm mass on the medial side of the right knee. Magnetic resonance imaging revealed a circumscribed soft tissue tumor located in the subcutaneous tissue. His previous doctor believed that it was benign and conducted a marginal resection. However, postoperative histology results demonstrated spindle cell sarcoma, following which the patient was referred to The Osaka International Cancer Institute. Localized cafe-au-lait spots were identified in the affected leg, which inferred that the patient had NF1-related MPNST. A wide resection was performed to completely resect the residual tumor; however, a definitive histological diagnosis was challenging due to the small residual tumor. Hence, the genomic mutations of NF1 in the regional cafe-au-lait spots were analyzed. The result revealed an NF1 microdeletion and a consistently limited expression of NF1 in the tumor sample. Finally, the patient was diagnosed with MPNST with mosaic localized NF1. Local recurrence and distant metastasis were not observed 1.5 years after surgery. In conclusion, the present report presented MPNST in an adolescent patient with mosaic localized NF1. The occurrence of MPNSTs correlated with mosaic localized NF1 is extremely rare. However, it is of high-grade malignancy and therefore, its clinical features should be considered by orthopedists and pathologists.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 50 条
  • [31] Different sized somatic NF1 locus rearrangements in neurofibromatosis 1-associated malignant peripheral nerve sheath tumors
    Pasmant, Eric
    Vidaud, Dominique
    Harrison, Marcus
    Upadhyaya, Meena
    JOURNAL OF NEURO-ONCOLOGY, 2011, 102 (03) : 341 - 346
  • [32] Malignant peripheral nerve sheath tumour (MPNST) arising in plexiform neurofibroma in a neurofibromatosis type I (NF1) patient
    Sykaras, A.
    Gioti, E.
    Stavrinou, N.
    Dolkiras, P.
    Christofidis, K.
    Kouvidou, C.
    VIRCHOWS ARCHIV, 2021, 479 : S307 - S307
  • [33] Malignant peripheral nerve sheath tumours in NF1: Improved survival in women and in recent years
    Ingham, Sarah
    Huson, Susan M.
    Moran, Anthony
    Wylie, James
    Leahy, Michael
    Evans, D. Gareth R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (18) : 2723 - 2728
  • [34] Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours
    Bottillo, Irene
    Ahiquist, Terje
    Brekke, Helge
    Danielsen, Stine A.
    van den Berg, Eva
    Mertens, Fredrik
    Lothe, Ragnhild A.
    Dallapiccola, Bruno
    JOURNAL OF PATHOLOGY, 2009, 217 (05): : 693 - 701
  • [35] Loss of heterozygoty (LOH) in malignant nerve sheath tumors (MNSTS) associated with neurofibromatosis 1 (NF1)
    Vidaud, D
    Leroy, K
    Wolkenstein, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 523 - 523
  • [36] A novel therapeutic approach to overcome resistance to glutaminase inhibition in NF1 driven malignant peripheral nerve sheath tumors MPNST
    Sheikh, Tahir
    Patwardhan, Parag
    Lu, Chao
    Schwartz, Gary K.
    CANCER RESEARCH, 2019, 79 (13)
  • [37] RAS pathway activation and sensitivity to therapeutic agents is correlated with NF1 residual activity in malignant peripheral nerve sheath tumors
    Kahen, Elliot
    Welch, Darcy
    Yu, Diana
    Cubitt, Christopher
    Lee, Jae
    Brohl, Andrew
    Reed, Damon R.
    CANCER RESEARCH, 2017, 77
  • [38] Genetic evaluation of malignant peripheral nerve sheath tumors (MPNSTs) from non-neurofibromatosis 1 (NF1) indmduals.
    Ota, M
    Ballard, L
    Coffin, C
    Parham, D
    Shearer, P
    Viskochil, D
    LABORATORY INVESTIGATION, 1997, 76 (01) : 926 - 926
  • [39] Malignant nerve-sheath tumor with divergent and glandular differentiation in a dog: A case report
    Patnaik, AK
    Zachos, TA
    Sams, AE
    Aitken, ML
    VETERINARY PATHOLOGY, 2002, 39 (03) : 406 - 410
  • [40] Malignant peripheral nerve sheath tumors in the setting of segmental neurofibromatosis - Case report
    Schwarz, J
    Belzberg, AJ
    JOURNAL OF NEUROSURGERY, 2000, 92 (02) : 342 - 346